Therapeutic Potential of Recombinant Allergens

Area of Science:

• Allergen immunotherapy
• Molecular biology
• Immunoregulation

Background:

• Recent molecular biology advances have enabled cDNA synthesis and primary structure determination of major allergens.
• This has led to the production of recombinant allergens and the identification of B- and T-cell epitopes.

Purpose of the Study:

• To explore novel therapeutic strategies for allergy treatment using recombinant allergens and epitopes.
• To discuss the potential advantages of these new strategies over existing immunotherapy.

Main Methods:

• Synthesis of recombinant allergens and their modified epitopes.
• Delineation of B- and T-cell epitopes.
• Evaluation of immunoregulation concepts for IgE antibody suppression or T-cell inactivation.

Main Results:

• Availability of pure, large quantities of recombinant allergens.
• Demonstration of cross-reactivities among aeroallergens.
• Identification of potential therapeutic targets for allergy suppression.

Conclusions:

• Novel therapeutic strategies based on modified recombinant allergens and epitopes show promise for allergy treatment.
• These approaches may offer advantages over conventional immunotherapy by targeting specific immune responses.